About the Company
Headquartered in Secaucus, New Jersey, Quest Diagnostics Inc. is a clinical laboratory. It has an approximate 47,000 employees working in its operations located across Ireland, India, Mexico and the United States. As of 2020, it has over 2,250 physician offices and around 6,600 patient access points in the US. The company owns 23 aircraft and 3,700 courier vehicles, alongside employing over 600 PhDs and MDs in its workforce.
It offers four categories of products and services pertaining to clinical trials testing, wellness & risk management, healthcare IT and diagnostic testing services. The company provides testing services for 27 types of medical conditions such as Arthritis, Genetics, HIV, Autoimmune Diseases, Neurology, Toxicology, Lymphoma, Lung Cancer, Paediatrics, General Health, Cardiovascular, Infectious Diseases, Celiac Disease etc. Quest focuses primarily on 17 types of medical specialists like Pulmonologist, Gastroenterologist, Maternal Foetal Medicine Practitioners, Rheumatologists, Dermatologists, Oncologists, Perinatologist, etc. As of 2020, its products are used by 130 countries from across the globe.
Quest Diagnostics offers its services to three categories of clients - patients, physicians & hospitals and organisations & companies. The company owns eight brands under it, named - AmriPath, Quest Diagnostics, ExamOne, Quantum Solutions, Athena Diagnostics, Quest HealthConnect, Dermpath Diagnostics and Quest Diagnostics Nichols Institute. Nicolas Institute performs specialised tests for laboratories and hospitals in 26 countries like Mexico, Peru, New Zealand, Taiwan, Chile, Japan, Peru, Australia, France, Panama etc.
Quest Diagnostics is one of the Fortune 500 companies and also a component in the S&P 500 list. It trades in the New York Stock Exchange under the ticker symbol DGX share. The company was founded in 1967 as Metropolitan Pathology Laboratory, Inc. by Paul A. Brown, MD. After two years its name changed to MetPath which was then changed to Corning Clinical Laboratories in 1982 after Corning Glass Works acquired it. By the end of 1996, Quest Diagnostics separated from Corning and became an independent company. From 2001 to 2020, it underwent 16 significant acquisitions like Memorial Hermann Health System’s outreach laboratory service business in 2020, Boyce & Bynum Pathology Laboratories’ clinical laboratory services business in 2019, Cleveland HeartLab, Inc. in 2017 and Summit Health, Inc. in 2014.;
|Organisation||Quest Diagnostics Inc|
|Industry||Diagnostics & Research|